Pharmacy

Aerie Pharmaceuticals CEO discusses what's new in the pipeline

Raj Kannan, the new CEO of Aerie Pharmaceuticals, talks with Ophthalmology Times' David Hutton about what's coming down the pipeline for Aerie.

ImprimisRx offers a look at three new products in the pipeline

ImprimisRx President John Saharek shares an update on a few of the company's latest products during AAO 2021.

Making the grade: FDA approves first biosimilar product for retinal diseases

The FDA has given its approval to Byooviz (ranibizumab-nuna, SB11, Samsung Bioepis Co Inc and Biogen Inc), a biosimilar referencing Lucentis (ranibizumab, Genentech).

(AAO) Genentech provides update on presentations, product portfolio

November 13, 2020

Chris Brittain, MBBS, BSc, MBA, MRCOphth, vice president and global head of ophthalmology product development for Genentech, provides an overview of the company’s podium presentations from the PDS with ranibizumab to faricimab.